Back to rankings
Imron Aly

Imron Aly

More information
ArentFox Schiff

ArentFox Schiff

United States • Chicago Elite

2

Intellectual property: contentious

Kevin Nelson, of ArentFox Schiff, is a  first–chair pharmaceutical and life sciences trial lawyer. Nelson is experienced in Hatch Waxman cases and IPR proceedings, as well as trying cases before the US Court of Appeals and the Federal Circuit. With expertise in pharmaceuticals, Nelson defends a range of generic drug, small molecule, and biosimilar companies, often with an international reach.
Legal 500 Editorial commentary
Phone
312.258.5523
Email
[email protected]
Profile
afslaw.com

Accolades

Chicago Elite

Profile

Work Department
IP Litigation
Position

Partner

Career

Imron is a trial lawyer who has served as lead counsel for clients on dozens of matters, and has first-chaired more than 15 trials. Imron’s practice is focused on patent infringement litigation and he is viewed as a go-to trial lawyer. He has litigated and tried patent infringement and other IP matters related to pharmaceuticals, medical implants and devices, DNA arrays, mechanical production assemblies, computer business methods, and financial trading systems. Clients and leading industry publications describe Imron as a prepared courtroom advocate whose “tenacity sets him apart,” who “stands out for his pure advocacy skills,” and “is an untiring advocate for his clients’ cause.”

Languages
English, Hindi
Memberships
Imron is an active member for the Center for Biosimilars Advisory Board. Additionally, he is a former board member of the Chicago Committee and Metropolitan Tenants Organization.
Education

Georgetown University Law Center, JD, magna cum laude; Order of the Coif; Georgetown Journal of Legal Ethics-Senior Articles Editor, 1999

Duke University, BSE, Biomedical Engineering, cum laude, 1996

Content supplied by ArentFox Schiff